India Shows Commitment to Pharma Excellence at CPhI Worldwide 2013

      India Shows Commitment to Pharma Excellence at CPhI Worldwide 2013

PR Newswire

FRANKFURT, Germany, Oct. 29, 2013

FRANKFURT, Germany, Oct. 29, 2013 /PRNewswire/ -- At CPhI Worldwide in
Frankfurt last week, Indian pharma's growth and future were the subject of a
number of interviews with key representatives of the Indian government,
industry, and the India Brand Equity Foundation (IBEF). The videos, produced
by CPhI Pharma Evolution TV (accessible here:
www.pharmaevolution.com/archives.asp?videoblogs=yes), examine India's pharma
sector from private and public perspectives. 

What emerges is the image of a government committed to ensuring growth and
quality, as well as senior corporate managers who are investing in
methodologies such as pharmaceutical quality by design (QbD) and technologies
such as continuous manufacturing to get there. India's motto at CPhI was:
"Credible, Affordable, and Sustainable."

Included among the interviews are:

  oSudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of
    Commerce and Industry, Government of India, emphasized India's commitment
    to pharmaceutical manufacturing and quality and its inherent strengths in
    skilled workforce, R&D, and chemistry. He outlined its parallel challenge
    of increasing access to affordable healthcare for its 1.2 billion
    citizens, as well as addressing the global market.
  oDr. S. E. Reddy, Deputy DCGI, Central Drugs Standard Control Organization,
    discussed the need for a dynamic approach to pharmaceutical regulation, to
    ensure product safety and efficacy.
  oDr. R. Ananthanaryanan, President, Dr. Reddy's Laboratories Ltd., talked
    about the country's strength in APIs and itsgrowing presencein finished
    formulations.
  oArvind Vasudevan, CEO, Aurobindo Pharma Ltd.'s formulation business,
    reviewed his company's plans as it moves into specialty injectables and
    biopharma markets, as well as plans to introduce new technology platforms,
    including continuous manufacturing of metformin.
  oAparna Dutt Sharma, CEO, IBEF, discussed IBEF's history and plans in the
    pharma sector."We're really in the business of storytelling," she said,
    and bringing the world a greaterunderstandingof India's strengths and
    contributions. She mentioned the fact that India is home to 24 Deming
    Prize winners, for instance, and that it has the world's second largest
    pool of scientists and engineers.
  oDr. P. V. Appaji, Director General, Pharmaceutical Export Promotion
    Council of India (Pharmexcil), discussed market growth and plans for
    Indian pharma. Pharma exports reached $14.7 billion in March of this year,
    he said, and by March 2016 they are expected to reach $25 billion.

These video interviews are available on CPhIPharmaEvolution.com, and
additional interviews with Dr. Reddy and Dr. Ananthanaryanan will be available
on the site later this week.

India Brand Equity Foundation (www.ibef.org), a trust foundation, aims to
promote the Made in India label in overseas markets. IBEFis a knowledge
center for global investors, international policy-makers, and world media
seeking updated, accurate, and comprehensive information on the Indian
economy, states, and sectors. IBEF regularly tracks government announcements
in policy, foreign investment, macroeconomic indicators, and business trends.

Contact:
Agnes Shanley
Editor in Chief, CPhI Pharma Evolution
agnes.shanley@ubm.com

About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical
supply chain from drug discovery to finished dosage. Through exhibitions,
conferences and online communities, CPhI brings together more than 100,000
pharmaceutical professionals each year to network, identify business
opportunities and expand the global market. CPhI hosts events in Europe,
China, India, Japan, Southeast Asia, Russia,IstanbulandSouth
Americaco-located with ICSE for contract services, P-MEC for machinery,
equipment & technology, InnoPack for pharmaceutical packaging and BioPh for
biopharma. CPhI provides an online buyer & supplier directory at
CPhI-Online.com and hosts a global community with news and analysis at
PharmaEvolution.com.

About UBM DeusM
UBM DeusM (www.deusm.com) is an integrated marketing services company owned by
UBM plc, targeting the fastest growing segment of the online publishing
industry: business social media. The company is led by Managing
DirectorStephen Saunders, Min's Marketer of the Year 2010. He and the other
UBM DeusM principals have built and delivered more than forty-five successful
sites and online communities over the last 2 years. UBM DeusM's service is
based on a unique platform, called Community in a Box (CiaB), which employs a
structured system of proven B2B Web publishing best-practices, combined with a
breakthrough integrated multimedia publishing platform ("n-Server") to enable
marketers to quickly and profitably set up specialized communities for their
target customers.

About UBM Live
UBM Live connects people and creates opportunities for companies across five
continents to develop new business, meet customers, launch new products,
promote their brands, and expand their markets.Through premier brands such
as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the
Concrete Show, and many others, UBM Live exhibitions, conferences, awards
programs, publications, Websites, and training and certification programs are
an integral part of the marketing plans of companies across more than 20
industry sectors.

SOURCE CPhI Pharma Evolution

Website: http://www.CPhIPharmaEvolution.com